You searched for "Nose"

1512 results found

Understanding the NAL-NL3 Prescription System: a new era of personalised hearing aid fitting

The NAL-NL3 system marks a transformative step in hearing aid fitting, shifting from a one-size-fits-most prescription to a modular, patient-centred approach. Developed by the National Acoustic Laboratories, this new system integrates a core audiogram-based prescription with targeted modules to address...

In conversation with Professor Jatin Shah

We are honoured to welcome renowned head and neck surgeon, Professor Jatin Shah as Guest Editor of this edition of ENT and Audiology News. Here he speaks to Section Editor, Charlie Giddings, about his career, memorable achievements and advice for...

Soluvos Medical is a corporate sponsor of the ELS

Everyone had hoped to see each other in person at the postponed 2020 ELS in Berlin. Instead, everyone will meet at the: Virtual European Laryngological Society meeting on 28th May 2021

Soluvos Medical wishes readers a great year end!

As the end of 2021 approaches, everyone is hoping that life can get back to a more socially active world.

Soluvos Medical ­­– official partner for COOK OHNS in BeNeLux

Soluvos Medical is proud to be an official partner for COOK OHNS in the BeNeLux region, as of 1 February 2022, for the COOK OHNS product line: Sialendoscopy, Biodesign Otologic repair, Doppler Blood Flow Monitor, Biodesign Dural repair.

Soluvos Medical is looking forward to the congress season 2022

The Soluvos team is preparing for the summer break. In the meantime, they can be found at the following events

Intraoperative identification of primary tumours in unknown primary head and neck cancer using transoral laser microsurgery with frozen sections

The aim of the study was to compare the sensitivity and specificity of intraoperative identification of primary tumours in patients with unknown primary head and neck squamous cell carcinoma (UP HNSCC) using transoral laser microsurgery (TLM) with frozen sections, with...

Extranodal extension following surgical resection of HPV-positive oropharyngeal cancer – is adjuvant radiotherapy alone sufficient?

Human papillomavirus (HPV) is a known aetiological factor in oropharyngeal squamous cell carcinoma (OPSCC). HPV-positive OPSCC is recognised to have a more favourable prognosis than HPV-negative disease. Treatment deintensification for HPV+ OPSCC has therefore been an area of research focus...

Combined use of a hearing aid and a cochlear implant: a case study

When multi-channel cochlear implants (CIs) were first introduced in the 1980s, their use was restricted to people who derived no benefit from conventional amplification. Over the past three decades, however, the criteria for CIs has been relaxed considerably, and it...

Unpacking the World Health Organization’s World Report on Hearing: what does it say?

The inaugural report on hearing from the World Health Organisation is a tool for advocacy, and for getting hearing loss on government agendas. Nguyen Ngoc Bao Tran was 11 months old when her hearing loss was diagnosed. Despite being informed...

Unpacking the World Health Organization’s World Report on Hearing: what does it say?

The inaugural report on hearing from the World Health Organisation is a tool for advocacy, and for getting hearing loss on government agendas. Nguyen Ngoc Bao Tran was 11 months old when her hearing loss was diagnosed. Despite being informed...

OTC hearing aids: where are we now?

The ‘Over-the-Counter Hearing Aid Act’ of 2017 set in motion plans for a long-debated shift in the hearing care market. In 2021, the FDA released draft guidance which will allow hearing aids in the US to be sold direct to...